Mark Baker
Impact in
-
- Malaria Research and Control
- Mosquito-borne diseases and control
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Malaria Research and Control 9
- Mosquito-borne diseases and control 2
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Martina Hagen (1 shared paper)Jörg J. Möhrle (6 shared papers)James McCarthy (6 shared papers)Louise Marquart (5 shared papers)Peter O’Rourke (5 shared papers)Paul Griffin (4 shared papers)Stephan Duparc (3 shared papers)Rob Hooft van Huijsduijnen (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Malaria Journal (3 papers)Infectious Diseases and Therapy (2 papers)Antiviral Therapy (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Mark Baker
21 papers receiving 767 citations
Peers
Comparison fields: 5 of 94
- Public Health, Environmental and Occupational Health 395
- Pharmacology 107
- Pharmaceutical Science 58
- Virology 36
- Computational Theory and Mathematics 126
Countries citing papers authored by Mark Baker
This map shows the geographic impact of Mark Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baker more than expected).
Fields of papers citing papers by Mark Baker
This network shows the impact of papers produced by Mark Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baker. The network helps show where Mark Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 139 | |
| 2 | 2017 | 105 | |
| 3 | 2016 | 83 | |
| 4 | 2007 | 80 | |
| 5 | 2014 | 71 | |
| 6 | 2016 | 52 | |
| 7 | 2016 | 49 | |
| 8 | 2015 | 35 | |
| 9 | 2022 | 35 | |
| 10 | 2022 | 34 | |
| 11 | 2006 | 31 | |
| 12 | 2016 | 30 | |
| 13 | 2014 | 15 | |
| 14 | 2014 | 15 | |
| 15 | 2018 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2012 | 2 |
About Mark Baker
Mark Baker is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Oncology, Computational Theory and Mathematics and Pharmacology, having authored 22 papers that have together received 794 indexed citations. Recurring topics across this work include Malaria Research and Control (9 papers), Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Computational Drug Discovery Methods (3 papers), Mosquito-borne diseases and control (2 papers), HIV Research and Treatment (2 papers) and Parasites and Host Interactions (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (395 citations), Pharmacology (107 citations), Pharmaceutical Science (58 citations), Virology (36 citations) and Computational Theory and Mathematics (126 citations). Mark Baker has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Martina Hagen, Jörg J. Möhrle, James McCarthy, Louise Marquart, Peter O’Rourke, Paul Griffin, Stephan Duparc, Rob Hooft van Huijsduijnen, Fiona Macintyre and Podjanee Jittamala. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Malaria Journal, Infectious Diseases and Therapy, Antiviral Therapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.